Cargando…
Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study
Background and objective Carcinoma of the urinary bladder is the most common urological cancer, and it accounts for 3.9% of all cancer cases in men. Patients with the subset of noninvasive low-grade papillary urothelial carcinoma (LG-UrCa) are at higher risk for tumour recurrence. In this study, we...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319871/ https://www.ncbi.nlm.nih.gov/pubmed/34336502 http://dx.doi.org/10.7759/cureus.16012 |
_version_ | 1783730538586046464 |
---|---|
author | Dutta, Satya Dey, Biswajit Raphael, Vandana Khonglah, Yookarin Mishra, Jaya Marbaniang, Evarisalin Kalita, Pranjal Sailo, Stephen |
author_facet | Dutta, Satya Dey, Biswajit Raphael, Vandana Khonglah, Yookarin Mishra, Jaya Marbaniang, Evarisalin Kalita, Pranjal Sailo, Stephen |
author_sort | Dutta, Satya |
collection | PubMed |
description | Background and objective Carcinoma of the urinary bladder is the most common urological cancer, and it accounts for 3.9% of all cancer cases in men. Patients with the subset of noninvasive low-grade papillary urothelial carcinoma (LG-UrCa) are at higher risk for tumour recurrence. In this study, we aimed to analyse the histopathological features of LG-UrCa and to correlate those with recurrence potential as well as disease stage and grade progression. Materials and methods We conducted a retrospective study from January 2016 to December 2018. All cases with presenting biopsy initially reported as LG-UrCa were included in the study. All cases with initial biopsy reported as high-grade papillary urothelial carcinoma (HG-UrCa) were excluded from the study. We used the 2016 World Health Organization/International Society of Urological Pathology (WHO/ISUP) guidelines for the classification of papillary urothelial neoplasm. Results A total of 48 initially diagnosed cases of LG-UrCa were identified. Two out of 48 cases were reclassified as high-grade urothelial carcinoma and were excluded from the study. The mean age of patients at presentation was 56.7 years. The mean duration of follow-up was 19.8 months. The mean size of initial tumours was 3.4 cm. Tumour recurrence was encountered in 14 (30.4%) of 46 patients. Out of the four patients who had high-grade progression (8.7%), two also developed TNM stage progression. These two patients eventually underwent radical cystectomy. Patients with larger initial tumour sizes were found to have an increased tumour recurrence rate (p=0.009). Patients with multiple lesions at initial diagnosis had a significantly higher tumour recurrence rate than those with a single tumour (p=0.02). There was no significant difference with regard to intravesical Bacillus Calmette-Guérin (BCG) and tumour recurrence (p=0.065). None of the clinicopathological parameters were significantly associated with the grade and/or stage progression. Conclusion Based on our findings, patients with larger initial tumour size and tumour multiplicity at presentation had an increased tumour recurrence rate. |
format | Online Article Text |
id | pubmed-8319871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-83198712021-07-31 Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study Dutta, Satya Dey, Biswajit Raphael, Vandana Khonglah, Yookarin Mishra, Jaya Marbaniang, Evarisalin Kalita, Pranjal Sailo, Stephen Cureus Pathology Background and objective Carcinoma of the urinary bladder is the most common urological cancer, and it accounts for 3.9% of all cancer cases in men. Patients with the subset of noninvasive low-grade papillary urothelial carcinoma (LG-UrCa) are at higher risk for tumour recurrence. In this study, we aimed to analyse the histopathological features of LG-UrCa and to correlate those with recurrence potential as well as disease stage and grade progression. Materials and methods We conducted a retrospective study from January 2016 to December 2018. All cases with presenting biopsy initially reported as LG-UrCa were included in the study. All cases with initial biopsy reported as high-grade papillary urothelial carcinoma (HG-UrCa) were excluded from the study. We used the 2016 World Health Organization/International Society of Urological Pathology (WHO/ISUP) guidelines for the classification of papillary urothelial neoplasm. Results A total of 48 initially diagnosed cases of LG-UrCa were identified. Two out of 48 cases were reclassified as high-grade urothelial carcinoma and were excluded from the study. The mean age of patients at presentation was 56.7 years. The mean duration of follow-up was 19.8 months. The mean size of initial tumours was 3.4 cm. Tumour recurrence was encountered in 14 (30.4%) of 46 patients. Out of the four patients who had high-grade progression (8.7%), two also developed TNM stage progression. These two patients eventually underwent radical cystectomy. Patients with larger initial tumour sizes were found to have an increased tumour recurrence rate (p=0.009). Patients with multiple lesions at initial diagnosis had a significantly higher tumour recurrence rate than those with a single tumour (p=0.02). There was no significant difference with regard to intravesical Bacillus Calmette-Guérin (BCG) and tumour recurrence (p=0.065). None of the clinicopathological parameters were significantly associated with the grade and/or stage progression. Conclusion Based on our findings, patients with larger initial tumour size and tumour multiplicity at presentation had an increased tumour recurrence rate. Cureus 2021-06-29 /pmc/articles/PMC8319871/ /pubmed/34336502 http://dx.doi.org/10.7759/cureus.16012 Text en Copyright © 2021, Dutta et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Pathology Dutta, Satya Dey, Biswajit Raphael, Vandana Khonglah, Yookarin Mishra, Jaya Marbaniang, Evarisalin Kalita, Pranjal Sailo, Stephen Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study |
title | Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study |
title_full | Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study |
title_fullStr | Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study |
title_full_unstemmed | Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study |
title_short | Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study |
title_sort | tumour behaviour of low-grade papillary urothelial carcinoma: a single-centre retrospective study |
topic | Pathology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319871/ https://www.ncbi.nlm.nih.gov/pubmed/34336502 http://dx.doi.org/10.7759/cureus.16012 |
work_keys_str_mv | AT duttasatya tumourbehaviouroflowgradepapillaryurothelialcarcinomaasinglecentreretrospectivestudy AT deybiswajit tumourbehaviouroflowgradepapillaryurothelialcarcinomaasinglecentreretrospectivestudy AT raphaelvandana tumourbehaviouroflowgradepapillaryurothelialcarcinomaasinglecentreretrospectivestudy AT khonglahyookarin tumourbehaviouroflowgradepapillaryurothelialcarcinomaasinglecentreretrospectivestudy AT mishrajaya tumourbehaviouroflowgradepapillaryurothelialcarcinomaasinglecentreretrospectivestudy AT marbaniangevarisalin tumourbehaviouroflowgradepapillaryurothelialcarcinomaasinglecentreretrospectivestudy AT kalitapranjal tumourbehaviouroflowgradepapillaryurothelialcarcinomaasinglecentreretrospectivestudy AT sailostephen tumourbehaviouroflowgradepapillaryurothelialcarcinomaasinglecentreretrospectivestudy |